Rajesh Hajela

Rajesh Hajela currently serves as Director at Arya Pharma South Africa, leading the market with Dynapayne and Dynadol since July 2024. In addition, Hajela has held the position of Director at Quantys Clinical Private Limited since January 2017, overseeing operations. Since January 2016, Hajela has also been a Director at Rusan Pharma Ltd, focusing on Technical and CQA along with Research and Development projects and SA marketing. Other notable roles include Director at NSRT and Plant Head Formulations at Ipca Laboratories Limited from May 2011 to January 2016, where responsibilities included managing the Ratlam formulation plant. Hajela's extensive experience includes key technical and managerial positions at Rusan Pharma Ltd, Pharmacare FZE, Cipla, and involvement in significant pharmaceutical projects, including an anticancer initiative in Iraq. Hajela holds a Bachelor of Engineering in Chemical Engineering from the University of Mumbai.